Clinical and Molecular Hepatology



Ahead-of print

Articles in E-pub version are posted online ahead of regular printed publication.

Original Articles Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
DOI: 10.3350/cmh.2023.0089  [Epub ahead of print]
Editorials Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
Do Young Kim
DOI: 10.3350/cmh.2023.0107  [Epub ahead of print]
Reviews Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
DOI: 10.3350/cmh.2023.0102  [Epub ahead of print]
Editorials Challenges in Translating Clinical Practice Guidelines into Real-Life Practice for the management of hepatocellular carcinoma in Taiwan
San-Chi Chen
DOI: 10.3350/cmh.2023.0101  [Epub ahead of print]
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
Shen-Yung Wang
DOI: 10.3350/cmh.2023.0082  [Epub ahead of print]
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Philipp Kasper, Münevver Demir, Hans-Michael Steffen
DOI: 10.3350/cmh.2023.0059  [Epub ahead of print]
Is liver biopsy mandatory to identify immune-tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
DOI: 10.3350/cmh.2023.0054  [Epub ahead of print]
Reviews Acute -on- Chronic liver failure – Terminology, Mechanisms and Management
Vinay Kumar BR, Shiv Kumar Sarin
DOI: 10.3350/cmh.2022.0103  [Epub ahead of print]
Editorials Management of Hepatocellular Carcinoma in China: Seeking Common Grounds While Reserving Differences
Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
DOI: 10.3350/cmh.2023.0106  [Epub ahead of print]
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
Ji-Won Park, Ki Tae Suk
DOI: 10.3350/cmh.2023.0085  [Epub ahead of print]
What should be done to reduce the discrepancy between guidelines and real-life practice for HCC in Korea?
Min Kyung Park, Yoon Jun Kim
DOI: 10.3350/cmh.2023.0080  [Epub ahead of print]
The clinical management of HCC in China: progresses and challenges
Shan Shan, Jidong Jia
DOI: 10.3350/cmh.2023.0077  [Epub ahead of print]
The current trends in the health burden of primary liver cancer across the globe
Peter Konyn, Aijaz Ahmed, Donghee Kim
DOI: 10.3350/cmh.2023.0092  [Epub ahead of print]
Changing the nomenclature from NAFLD to MAFLD is more than a change in terminology
Eileen Laurel Yoon, Dae Won Jun
DOI: 10.3350/cmh.2023.0086  [Epub ahead of print]
Editorial: HCC surveillance in non-alcoholic fatty liver disease – who and how?
Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
DOI: 10.3350/cmh.2023.0069  [Epub ahead of print]
Implications of comorbidities in nonalcoholic fatty liver disease
Sherlot Juan Song, Vincent Wai-Sun Wong
DOI: 10.3350/cmh.2023.0066  [Epub ahead of print]
Reviews Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
DOI: 10.3350/cmh.2022.0420  [Epub ahead of print]
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong-Won Park
DOI: 10.3350/cmh.2023.0099  [Epub ahead of print]
Editorials The prime time for management of hepatocellular carcinoma in Hong Kong
Landon L. Chan, Stephen L. Chan
DOI: 10.3350/cmh.2023.0094  [Epub ahead of print]
Non-obese or lean nonalcoholic fatty liver disease matters but is it preventable or inevitable in light of its risk factors?
Heejoon Jang, Won Kim
DOI: 10.3350/cmh.2023.0088  [Epub ahead of print]
The Imitator of Immune-Tolerant Phase in Chronic Hepatitis B: A Killer in Disguise
Moon Haeng Hur, Jeong-Hoon Lee
DOI: 10.3350/cmh.2023.0079  [Epub ahead of print]
The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
DOI: 10.3350/cmh.2023.0070  [Epub ahead of print]
Lean vs. obese NAFLD, two phenotypes of NAFLD: look the same but different or vice versa?
Ho Soo Chun, Minjong Lee
DOI: 10.3350/cmh.2023.0061  [Epub ahead of print]
Reviews Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
DOI: 10.3350/cmh.2022.0434  [Epub ahead of print]
Original Articles Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
DOI: 10.3350/cmh.2022.0330  [Epub ahead of print]
Editorials The growing burden of non-alcoholic fatty liver disease on mortality
Ju-Yeon Cho, Won Sohn
DOI: 10.3350/cmh.2023.0084  [Epub ahead of print]
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Byeong Geun Song, Dong Hyun Sinn
DOI: 10.3350/cmh.2023.0058  [Epub ahead of print]
Reviews A decade of liver organoids: Advancements in disease modeling
Yue Liu, Jian-Ying Sheng, Junjun Ding, Yun-Shen Chan
DOI: 10.3350/cmh.2022.0428  [Epub ahead of print]
Original Articles Analysis of Hepatitis C Virus Resistance-Associated Substitutions in Direct-Acting Antiviral Failure in South Korea Using Next-Generation Sequencing
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
DOI: 10.3350/cmh.2022.0345  [Epub ahead of print]
Editorials Editorial: Noninvasive biomarkers for liver inflammation in NAFLD: current and future
Kee-Huat Chuah, Wah-Kheong Chan
DOI: 10.3350/cmh.2023.0062  [Epub ahead of print]
The Independent Effect of Exercise on Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review
Young-Joo Jin
DOI: 10.3350/cmh.2023.0055  [Epub ahead of print]
Snapshot Systemic therapy in advanced hepatocellular carcinoma
Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
DOI: 10.3350/cmh.2023.0051  [Epub ahead of print]
Reviews Acute hepatitis C virus infection: clinical update and remaining challenges
Chen-Hua Liu, Jia-Horng Kao
DOI: 10.3350/cmh.2022.0349  [Epub ahead of print]
Original Articles Taurocholic Acid Promotes Hepatic Stellate Cell Activation via S1PR2/p38 MAPK/YAP Signaling under Cholestatic Conditions
Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun
DOI: 10.3350/cmh.2022.0327  [Epub ahead of print]
Correspondance Correspondence on Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"
Jeong-Ju Yoo, Sang Gyune Kim
DOI: 10.3350/cmh.2023.0044  [Epub ahead of print]
Reviews Development of hepatocellular carcinoma in untreated and treated patients with chronic hepatitis B virus infection
Chih-Lin Lin, Jia-Horng Kao
DOI: 10.3350/cmh.2022.0342  [Epub ahead of print]
Editorial Non-invasive biomarkers of liver fibrosis in NAFLD
Basheer M, Naffaa ME, Assy N
DOI: 10.3350/cmh.2023.0045  [Epub ahead of print]
Reviews Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
DOI: 10.3350/cmh.2022.0391  [Epub ahead of print]
Original Articles Factors Associated with Unrecognized Cirrhosis in Patients with Hepatocellular Carcinoma
Yi-Te Lee, Mohammad Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
DOI: 10.3350/cmh.2022.0450  [Epub ahead of print]
Reviews Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J. Tuñón, Javier González-Gallego, José L. Mauriz
DOI: 10.3350/cmh.2022.0425  [Epub ahead of print]
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
DOI: 10.3350/cmh.2022.0422  [Epub ahead of print]
Letter to the Editor Letter to the Editor: Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"
Chia-Ming Chu, Yun-Fan Liaw.
DOI: 10.3350/cmh.2023.0018  [Epub ahead of print]
Reviews Clinical practice guidelines and real-life practice for hepatocellular carcinoma in Taiwan
Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu
DOI: 10.3350/cmh.2022.0421  [Epub ahead of print]
Utility of Combining PIVKA-II and AFP in the Surveillance and Monitoring of Hepatocellular Carcinoma in the Asia-Pacific Region
Do-Young KIM, Bao Nguyen TOAN, Chee-Kiat TAN, Irsan HASAN, Lyana SETIAWAN, Ming-Lung YU, Namiki IZUMI, Nguyen Nguyen HUYEN, Pierce Kah-Hoe CHOW, Rosmawati MOHAMED, Stephen Lam CHAN, Tawesak TANWANDEE, Teng-Yu LEE, Thi Thanh Nguyen HAI, Tian YANG, Woo-Chang LEE, Henry Lik Yuen CHAN
DOI: 10.3350/cmh.2022.0212  [Epub ahead of print]
The role of different viral biomarkers on the management of chronic hepatitis B For special issue ‘Challenging issues in the treatment of viral hepatitis’
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
DOI: 10.3350/cmh.2022.0448  [Epub ahead of print]
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
DOI: 10.3350/cmh.2022.0404  [Epub ahead of print]
Original Articles The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase
Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
DOI: 10.3350/cmh.2022.0322  [Epub ahead of print]
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences, 1990-2019: a DALYs-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
DOI: 10.3350/cmh.2022.0316  [Epub ahead of print]
Reviews Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective
Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
DOI: 10.3350/cmh.2022.0399  [Epub ahead of print]
Clinical practice guideline and real-life practice in hepatocellular carcinoma: Chinese perspective
Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
DOI: 10.3350/cmh.2022.0402  [Epub ahead of print]
Original Articles Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
Kathryn Jane Waller, Hajar Saihi, Wenhao Li, James Hallimond Brindley, Anja De Jong, Wing-kin Syn, Conrad Bessant, William Alazawi
DOI: 10.3350/cmh.2022.0205  [Epub ahead of print]

Go to Top